During the past decade, MB & V Medical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MB & V Medical Research" are "MAC Lung Disease" (1 trials), "Treatment Refractory MAC Lung Disease" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "MB & V Medical Research" in a lesser frequency.

Most popular intervention types in "MB & V Medical Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Cobitolimod 250 mg" (1 trials), "Cobitolimod 500 mg" (1 trials) and "Epetraborole" (1 trials). Other intervention names were less common.

The vast majority of trials in "MB & V Medical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MB & V Medical Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MB & V Medical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MB & V Medical Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".